The second session of the TCS PIONEER Series, held on 29 October, focused on Strong Patents that Last: Drafting Specifications and Claims that Withstand Scrutiny.

Pauli shared practical perspectives on effective patent drafting strategies, including the importance of supporting data, clear disclosures, adequate claim support, and common patent drafting pitfalls to avoid. Participants also went through practical exercises to experience drafting claims and conducting technical comparisons.

We are delighted to continue contributing to this initiative and look forward to the remaining sessions covering prior art and freedom-to-operate analyses, as well as strategic filing and global patent protection.

Learn more about the programme: 🔗 TCS PIONEER Series Details

我们的过去活动

Recommended Insights

Updates on Hong Kong Patents Examination Guidelines in 2024

2024年2月29日
The Intellectual Property Department of the Government of the Hong Kong Special Administrative Region of the People’s Republic of China (HKIPD) has recently made several updates to the Hong Kong Patents Examination Guidelines, effective from 26 January, 2024. These changes mainly clarify and reflect the Registry’s current practices regarding patent examination for Standard Patent (R) […]

China Top 10 Cases of 2020 – CNIPA Upholds Second Medical Use Patent from University of Bordeaux

2021年5月24日
The development of China’s approach to patents, especially those in the pharmaceutical and biotech space, has been fascinating to watch. Those of us who have practiced in the area for a long time have been frustrated by the Chinese patent office’s overly strict rules regarding patentability (e.g., high data support standard and refusal to consider […]

Patent Inventiveness in China: Why “Common Knowledge” Must Be Proven, Not Assumed

2026年8月14日
A Case Study of the "Electronic Blackboard" Case, (2025) SPC Zhi Xing Zhong No. 286 I. Introduction In assessing inventive step for invention patents, determining whether a technical solution would have been “readily conceivable” to a person skilled in the art has long been one of the most disputed and uncertain aspects of the analysis. […]

A Stratification Too Far? How the CNIPA Draws the Line on Patient Subgroups in a Recent Precision Medicine Invalidation Case

2026年2月27日
Precision medicine is rapidly transforming the global healthcare landscape, providing more effective therapies and better patient outcomes through targeted solutions. As therapeutics move away from the traditional “one-size-fits-all” model, unique challenges are presented in the patent examination process. The 2024 Top 10 Patent Re-examination and Invalidation case highlighted below provides further insight into how the […]
Top crossarrow-right